MedPath

Evidence based evaluation of Qufeng Rougan Xiaobai recipe in the treatment of advanced vitiligo and its effect on circulating markers

Phase 1
Conditions
vitiligo
Registration Number
ITMCTR2200006388
Lead Sponsor
Chongqing Hospital of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

1.non-segmental vitiligo in the progressive period
2.TCM syndrome differentiation is wind pathogen with blood stasis syndrome
3.1%4.18=age=60
5.no systematic treatment in recent 3 months, no physical therapy in recent 1 month
6.no other skin diseases need to be treated, and no other serious diseases of important organs

Exclusion Criteria

1.patients with difficulty in follow-up
2.acral vitiligo
3.pregnant and lactating patients
4.refuse to sign informed consent

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the change of white area;
Secondary Outcome Measures
NameTimeMethod
DLQI;the adverse event;the change of white spot color;circulating biomarker;
© Copyright 2025. All Rights Reserved by MedPath